Top in women's health: Residents alter plans after Dobbs; misoprostol alone is effective

In a recent survey, nearly 18% of OB/GYN residents reported that the Dobbs decision impacted their plans for practice or fellowship.

The data further showed that residents who planned to work in restrictive states were eight times more likely to change their career plans compared with those who already planned to practice in states with fewer restrictions. Researchers said the findings provide evidence for policymakers that demonstrates the importance of abortion access to the health care workforce. It was the top story in women’s health last week.

The second top story covered emerging evidence that misoprostol alone is an effective option for medical abortion. In a recent study, nearly all women who took the drug successfully terminated their pregnancy without a procedural intervention.

Read these and more top stories in women’s health below:

OB/GYN residents: Less desire to practice in states with abortion restrictions

OB/GYN residents report a reduced desire to practice or pursue a medical fellowship after their residency in states with more abortion restrictions, according to survey findings published in Obstetrics & Gynecology. Read more.

Misoprostol alone highly effective for pregnancy termination

Use of misoprostol alone, without a procedural intervention, was an effective method for terminating pregnancy, which offers more options for women seeking medical abortion, researchers reported in JAMA Network Open. Read more.

Therapeutic lifestyle modifications play important role in PCOS management

For women with polycystic ovary syndrome, therapeutic lifestyle modifications help to regulate menstruation, improve glucose metabolism and increase fertility, according to a speaker at the Lifestyle Medicine Conference. Read more.

Better outcomes seen with delay in next frozen embryo transfer after pregnancy loss

Delaying frozen embryo transfer for at least 6 months after clinical pregnancy loss was linked to better pregnancy outcomes vs. shorter interpregnancy intervals, according to study findings published in JAMA Network Open. Read more.

HPV detectability linked to better cervical cancer prognoses

HPV detectability was associated with better clinical cervical cancer prognosis vs. no detectable virus with up to a 41% lower mortality risk, according to a systematic review and meta-analysis published in Obstetrics & Gynecology. Read more.